Conditioning for bone marrow transplantation (BMT) may alter viability of germ cells and production of gonadal hormones. We analyzed the risk factors for gonadal failure after 12 Gy total body irradiation (TBI) given as six fractions (n = 31, group 1), 10 Gy (one dose) TBI (n = 20, group 2), 6 Gy (one dose) total lymphoid irradiation (TLI, n = 17, group 3) and chemotherapy alone (n = 7, group 4), given at 7.7 ± 0.4 (0.6-13.6) years. Among the 34 girls, seven (20.6%) had normal ovarian function with regular spontaneous menstruation and normal plasma follicle-stimulating (FSH) and luteinizing (LH) hormones, five (14.7%) had partial ovarian failure with regular menstruation but increased FSH and/or LH, and 22 (64.7%) had complete ovarian failure. The 24 girls with chronological and bone ages Ͼ13 years included similar percentages, with increased FSH or LH in all four groups. There was a positive correlation between age at BMT and FSH (r = 0.54, P Ͻ 0.01), but not with LH, and between FSH and LH (r = 0.8, P = 0.0003). Plasma FSH concentrations had returned to normal spontaneously in six cases, and those of LH in two cases. Among the 41 boys, 16 (39%) had normal testicular function and 25 (61%) had tubular failure and increased FSH. Of these, 10 also had Leydig cell failure (three complete and seven partial). The 18 boys with chronological and bone ages Ͼ15 years included similar percentages with increased FSH or LH in groups 1 to 3, and testicular volume was significantly lower in group 2 than in group 3 (P = 0.008). There was no correlation between age at BMT and FSH, LH or testosterone, but there was a negative correlation between FSH and inhibin B (rho = −0.87, P Ͻ 0.003). We conclude that girls are more likely to suffer ovarian failure the older they are at BMT, and that early ovarian recovery is possible. Keywords: bone marrow transplantation; fertility; inhibin; irradiation; ovary; testis Conditioning for bone marrow transplantation (BMT) may alter the production of gonadal hormones (estradiol and progesterone in girls, testosterone in boys) and the viability of germ cells.
Conditioning for bone marrow transplantation (BMT) may alter the production of gonadal hormones (estradiol and progesterone in girls, testosterone in boys) and the viability of germ cells. [1] [2] [3] Gonadal failure results in incomplete sexual development and growth at puberty, and sterility in adulthood. Gonadal hormones are required for the development of secondary sexual characteristics, and for the growth acceleration which normally occurs at puberty.
The risk factors for gonadal failure in patients undergoing BMT are difficult to analyze because of the variety of conditioning regimens used, and the possibility of gonadal recovery. 4 This study analyzes the expression and frequency of gonadal failure in both sexes according to the conditioning protocol, and the significance of the age during childhood at which BMT is carried out. We also measured plasma inhibin B concentrations as an additional marker of tubular function in these young patients where semen analysis is not possible.
Patients
The gonadal function of 75 patients (34 girls and 41 boys) who received a BMT during childhood, and who were aged more than 10 years at the last evaluation, was followed up in the Pediatric Endocrinology Department of Hôpital Necker-Enfants Malades in Paris. Nineteen girls were included in a previous study. 5 Five other patients were excluded because of the possibility of associated gonadotropin deficiency due to the hemosiderosis of thalassemia major (n = 3) or Blackfan Diamond disease (n = 2). None of them had any central nervous system involvement at diagnosis, nor had they been given irradiation other than total body irradiation (TBI). Chronic graft-versus-host disease occurred in 28 cases (cases 9, 11, 12, 17, 18, 21, [23] [24] [25] 27 , 29 and 31 in girls and cases 5, 9, 11, 12, 15, 18, 19, 21, 26, 29, 30 , 33, 35-37 and 39 in boys) and had been treated with corticosteroids and cyclosporine. All were in remission without complications. Patients were assigned to one of four groups according to the type of conditioning regimen given (Tables 1 and 2 ). Patients in group 1 (n = 31) were given 12 Gy TBI as six fractions of 2 Gy over 3 consecutive days; those in group 2 (n = 20) were given 10 Gy TBI; those in group 3 (n = 17) were given 5 or 6 Gy total lymphoid irradiation (TLI) as single 4-h exposures; and those in group 4 (n = 7) had chemotherapy alone. The irradiation was delivered to group 1 patients with a 5.5 mV linear accelerator at 50 cGy/min, and to those of groups 2 and 3 with a 18 mV linear accelerator at 4.2 cGy/min. The chemotherapy protocol was as previously reported. 6 Chemotherapy was given before BMT in cases 1-22, 33 
Methods
Evaluations were performed after informed consent had been obtained from the patients and their parents. In girls we recorded the age at breast development, and the occur- rence and progress of menstruation; 7 in boys we recorded testicular dimensions. 8, 9 The basal plasma concentrations of estradiol in girls and testosterone in boys, and of gonadotropins (follicle-stimulating hormone, FSH and luteinizing hormone, LH), were evaluated in all subjects. Individual values of plasma estradiol were not used because they correspond to the time of the cycle. The values of testicular dimensions, FSH, LH and testosterone were interpreted according to both chronological and bone ages because of bone age delay in some patients. These were assessed by one of us (RB) by the Greulich and Pyle method. 10 Fifty patients (19 girls and 31 boys) had more than one laboratory evaluation. The laboratory evaluations of the patients given sex steroid replacement therapy were performed after stopping this therapy for at least 2 months. An aliquot of plasma was frozen at −20°C to measure inhibin B 11 in 14 boys with chronological and bone ages Ͼ15 years. Normal gonadal function was defined by the occurrence of spontaneous pubertal development and normal plasma gonadotropins (FSH Ͻ9 U/l and LH Ͻ5 U/l at age of puberty). Normal plasma testosterone concentrations in adult males are 3.5 to 8.5 g/l. In girls, complete gonadal failure was defined by an absence of the occurrence or progression of pubertal development, low plasma estradiol, and increased plasma gonadotropin concentrations. Partial gonadal failure was defined by the occurrence of spontaneous pubertal development and normal plasma sex steroid, but increased plasma gonadotropin concentrations. In boys, tubular failure was defined by a partial or complete absence of any increase in testicular volume at pubertal age, and/or increased plasma FSH. Partial Leydig cell failure was defined by a normal plasma testosterone but increased plasma LH; complete Leydig cell failure was defined by low plasma testosterone and increased plasma LH. Patients with complete gonadal failure were given oral ethinyl estradiol (2 g/day) at the age of around 12 years (for girls), or testosterone heptylate (25 mg i.m. every 15 days) at around 13 years (for boys) during their growing period. At the end of this period, the dose was increased to adult levels and, in girls, given with cyclical progestin. Hypothalamic-pituitary function was assessed in those given TBI, and plasma thyroid stimulating hormone in those given TBI or TLI. 6 Associated growth hormone deficiency was found in 29 patients (20 boys), among them, 28 had been treated with growth hormone. Associated thyroid deficiency was found in 31 patients (21 boys), who had been treated with thyroxin.
Data are expressed as means ± s.e.m. The differences between groups were analyzed by a Kruskall Wallis test, followed by Mann-Whitney tests. Correlations were made with the Spearman rank test.
Results

Girls
The means chronological ages were 7.2 ± 0.6 (0.6 to 13.1) years at BMT, 12.4 ± 0.3 (10 to 17.3) years at the first laboratory gonadal evaluation, and 14.3 ± 0.4 (10.1 to 19.7) years at the last one. At the time of BMT, 31 girls were prepubertal, and breast development had begun in three;
Bone Marrow Transplantation one had begun to menstruate (Table 1) . Menarche occurred spontaneously in 12 girls, at 13.9 (10.6 to 16) years. The plasma FSH concentrations had returned spontaneously to normal in cases 7, 16, 18, 26, 28 and 33, and those of LH in cases 7 and 28 (Figure 1 ). At the last evaluation, seven (20.6%) girls had normal ovarian function with regular menstruation, five (14.7%) had partial ovarian failure with regular menstruation but increased plasma FSH and/or LH concentrations, and 22 (64.7%) had complete ovarian failure. Estrogen was given to 18 girls. Four girls were too young to be given substitutive therapy.
The data for the 24 girls aged 13 years at the last laboratory evaluation were compared in the four groups. The chronological and bone ages at the last evaluation were similar, as were the intervals between the BMT and this evaluation. The percentages of girls with increased plasma FSH (75, 67, 71 and 33% in groups 1 to 4) or LH (67% in groups 1 to 3, respectively, and 33% in group 4) concentrations were similar in the four groups. There was a positive correlation between age at BMT and plasma FSH (r = 0.54, P Ͻ 0.01), but not with LH; there was also a positive correlation between FSH and LH concentrations (r = 0.8, P = 0.0003).
Boys
The mean chronological ages were 8.1 ± 0.5 (2 to 13.6) years at BMT, 12.7 ± 0.2 (8.3 to 16.6) years at the first laboratory gonadal evaluation, and 14.7 ± 0.3 (11 to 20.6) years at the last one. Pubic hair development and testicular volume at the time of BMT were not recorded. At the last evaluation, 16 (39%) boys had normal testicular function and 25 (61%) had tubular failure (Table 2, Figure 2 ). Among these, 10 also had Leydig cell failure (three complete and seven partial, Figure 3) . Testicular volume and FSH were not in agreement in cases 7, 16 and 36. Testosterone heptylate was given to the three boys with complete Leydig cell failure (cases 25, 27 and 36).
The data for the 18 boys aged Ͼ15 years at the last laboratory evaluation were compared in groups 1 to 3, excluding the two boys given chemotherapy alone, who had normal testicular function. The chronological and bone ages at the last evaluation were similar, as were the intervals between the BMT and this evaluation. Testicular volume was significantly lower in group 2 than in group 3 (P = 0.008). The percentages of boys with increased plasma FSH (57, 100 and 57% in groups 1 to 3) or LH (29, 75 and 14%) concentrations were similar in the three groups. There was no correlation between age at BMT and plasma FSH, LH or testosterone concentrations, nor between these three concentrations when compared to each other. There was a negative correlation between inhibin B and FSH (rho = −0.87, P Ͻ 0.003), but there was no correlation between inhibin B and testicular volume, plasma LH or testosterone concentrations.
The ages at BMT of girls aged Ͼ13 years and boys Ͼ15 years with normal FSH or LH concentrations were similar to those with increased concentrations. FSH, IU/I 
Discussion
This study shows that in patients given BMT during childhood: (1) the frequency of the gonadal failure did not differ according to the conditioning protocol, but a 10 Gy single TBI dose resulted in lower testicular volume than a 6 Gy single TLI; (2) the older a girl is at BMT, the more likely she is to have increased FSH concentrations, and the concentrations of FSH and LH are highly correlated; (3) there was negative correlation between FSH and inhibin B in boys; (4) plasma gonadotropin concentrations may be increased as early as bone age 10 years.
The 34 girls given BMT included 20.6% with normal ovarian function and regular menstruation, 14.7% with regular menstruation but increased plasma FSH and/or LH concentrations, and 64.7% with complete ovarian failure. These frequencies are similar to those reported, 12, 13 but the frequency of increased plasma FSH concentration after TBI was no greater than after chemotherapy. This is different from the reports of others, 13 and may be due to the small number of patients conditioned by chemotherapy alone. This study confirms that older age at BMT is associated with higher frequency of ovarian failure. [12] [13] [14] this recovery varies. In a study of 82 prepubertal girls who underwent BMT and were aged over 12 years at evaluation, 23 (28%) girls developed normal ovarian function, including nine who became pregnant. 4 All the pregnancies of the five who were given TBI ended in spontaneous abortion. Low birth weight is more frequent in women given abdominal irradiation for Wilms' tumor during childhood 15 and in those given TBI after puberty. 4 This is attributable to fibrosis and to alterations in the vascularization of the myometrium.
The 41 boys given BMT were more likely to have altered germ cells with increased plasma FSH (61%), than altered testosterone secretion, which is partially or completely altered with increased LH (24.4%), as shown by others. 12, 16 Treatment with testosterone was indicated in only three patients. Testicular volume was lower in those given 10 Gy TBI than in those given 6 Gy TLI, both delivered as a single dose. The boys showed no relationship between age at BMT and plasma gonadotropin concentrations. This is in disagreement with the data reported after testicular irradiation for leukemia, 17, 18 or conditioning for BMT, 12 showing that younger boys are likely to have Leydig cells that are more vulnerable to irradiation. The reverse was reported by Mertens et al, 13 who found that the proportion of individuals with increased LH at their last clinical evaluation increased significantly with age at BMT. We found Bone Marrow Transplantation no decrease to normal values in the gonadotropin concentrations, in contrast to the girls, and with the reported data. 13 Sanders et al 4 showed that 157 of a total of 618 post-pubertal men recovered testicular function and the partners of 33 of them became pregnant; while 15 (13%) of 114 prepubertal boys developed normal gonadal function and the partners of two of them became pregnant. The large majority of those who recovered testicular function had been given cyclophosphamide, without irradiation.
We measured plasma inhibin B concentrations, as semen analysis was not yet possible in these young patients, and because these concentrations are correlated with sperm concentrations. 19 We found a negative correlation between inhibin B and FSH concentrations. Wallace et al 20 found that inhibin B fell 1 month after chemotherapy for hematological malignancies, and that FSH increased within the first month. Both reached plateau values at 4 months, did not change thereafter until 12 months, and were significantly and negatively correlated. Petersen et al 21 found that all 25 patients had undetectable concentrations (Ͻ20 pg/ml) of inhibin B 2-12 months after testicular irradiation (2 Gy, 7-10 times).
Height gain during puberty accounts for 16% of the total adult height. As body irradiation may be followed by a great reduction in adult height, 22 it is important to give children with gonadal failure sex steroid treatment at the time they need it to reach their best adult height. Patients given BMT should be seen for clinical pubertal evaluation at 11-12 years in girls and 12-13 years in boys. Their basal plasma FSH and LH should be measured at this age, and slightly later in those with bone age retardation or undergoing catch-up growth due to growth hormone treatment. Basal plasma estradiol need not be routinely measured in girls who have no spontaneous breast development, as it should be in the prepubertal range. Measurement of basal plasma testosterone in boys is more useful, as it allows evaluation of the role of the testis in the development of pubic and axillary hair, which is in part influenced by adrenal hormones. Patients with gonadal failure should be given sex steroid replacement therapy. There are two phases in this treatment: a low dose to accelerate growth during the growing period, without excessive bone age progression; and a dose increased to the adult level at the end of growth and, in girls, given cyclically to induce regular menstruation. Sex steroid replacement therapy should be stopped for 2 months at regular intervals to check for gonadal recovery. Measurements of plasma inhibin B may help to assess tubular function before boys are old enough for semen analysis.
